WHO ICTRP trial
Orodispersible Minitablets of Enalapril in young children with Heart Failure due…
NL-OMON45974 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON45974 |
|---|---|
| Public title | Orodispersible Minitablets of Enalapril in young children with Heart Failure due to Congenital Heart Disease (WP09 Trial) |
| Scientific title | Orodispersible Minitablets of Enalapril in young children with Heart Failure due to Congenital Heart Disease (WP09 Trial) - WP09 Trial |
| Primary sponsor | Ethicare GmbH |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 2 |
| Countries | Austria;Germany;Hungary;Netherlands;Serbia |
| Conditions | Congenital heart disease heart failure;10010394;Congenital heart disease;heart failure |
| Interventions | GROUP A First dose: clinically comparable dosing of ACEI previously used GROUP B First dose of one or two 0.25 mg ODMTs in accordance with the dose banding dosing regimen provided in this protocol, administered orally. If there is no… |
| Registration date | Nov 27, 2017 |
| Target size | 5 |
| Secondary IDs | 2015-002396-18;NL54738.078.15 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: